Navigation Links
PETCO Stores Nationwide Host Pet Nutrition Workshops
Date:11/9/2009

SAN DIEGO, Nov. 9 /PRNewswire/ --

    WHAT:     All PETCO stores nationwide will host a free pet nutrition
              workshop facilitated by specially trained in-store nutrition
              experts on Saturday, November 14 at 2 p.m.  During the 30-minute
              workshop, pet parents will learn about the nutritional needs of
              their dogs and cats, have a chance to discuss the benefits of
              good pet nutrition, receive an assessment of their individual
              pet's nutrition needs and understand the difference between
              basic, premium and natural pet food categories.

              Pet parents who attend the event will receive educational
              materials and free food samples from food suppliers Wellness,
              Halo, and Natural Balance

    WHEN:     Saturday Nov. 14
              2 p.m.

    WHERE:    All PETCO locations nationwide

    VISUALS:  -- Interviews with pet nutrition specialists and newly educated
              pet parents

For more information:

To find a local PETCO store, visit www.petco.com/storelocator

For more information on PETCO's Nutrition Training, visit www.petco.com/nutritioncenter

SOURCE PETCO Animal Supplies


'/>"/>
SOURCE PETCO Animal Supplies
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Author Kris Carr to Sign Crazy Sexy Cancer Tips at Two Borders(R) Stores in California
2. Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?
3. Governor Rendell Announces CHIP Enrollment Clinics at Several Rite Aid Stores
4. NFL-Themed Milk Touches Down in Schools and Retail Grocery Stores
5. An Innovation in Health Care Opens at CVS/pharmacy Stores in Philadelphia Metro Area
6. An Innovation in Health Care Opens at CVS/pharmacy Stores in Pittsburgh
7. An Innovation in Health Care Opens at CVS/pharmacy Stores in Los Angeles Metro Area
8. CVS/pharmacy to Remove OTC Infant Cough & Cold Products from Its Stores as Part of CHPAs Voluntary Withdrawal
9. Kidz-Med to Launch the Thermofocus(R) 5-in-1 Exclusively at Walgreens Stores Nationwide
10. HearAtLast Continues Rapid Expansion, Opening Two New Retail Locations in Richmond Hill and Markham Wal-Mart Stores Number 3195 and 3053
11. Shopko Announces Plans for Two New Stores

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...itationforFivePopulationHealthPrograms ,, LOVE...tionHealthImpactInstitute(PHII),anon-profit501(c)(...ofDirectorshasapprovedtheHealthcareTransparencyAcc...velopment.Nurtur(TM),alife,health,andwellnesscompa...ivetheH-TAPaccreditationsealforfiveofitsprograms. ...
(Date:11/23/2009).../PRNewswire/--ChristineHoehnehasjoined LocktonBene...brokerage.HoehnewillserveasanAccountExecutiveinLoc...ton,s Minneapolis office. ,, (Logo: http://www...., "WearethrilledtohaveChristinejoinourteam,"said...rvices."Shebroadensourabilitytoassistourmultinatio...
(Date:11/23/2009)...splants need longer-term support than most friends...se, according to a study of 160 patients published... Advanced Nursing . , Researchers surveyed 5...ear, together with 105 who had had surgery in the ...nt Center in Tennessee, USA. They wanted to see if...
(Date:11/23/2009)...1, has understandably captured the attention of pu...owever, an analysis from Children,s Hospital Bosto...ent (ED) during several recent flu seasons, shows ...SV) -- takes a substantially greater disease toll ...lthough the data come from the pre-H1N1 influenza ...
(Date:11/23/2009)...te Helps Organizations Meet HIPAA Compliance Requi...nd Eligibility, , (PRWEB)...leading provider of high-performance data integrat...y the launch of new products within its healthcare... other healthcare organizations meet industry stan...
Breaking Medicine News(10 mins):Health News:Population Health Impact Institute Launches Healthcare Transparency Accreditation Program(TM) 2Health News:Population Health Impact Institute Launches Healthcare Transparency Accreditation Program(TM) 3Health News:Lockton Benefit Group Expands International Benefit Team 2Health News:Drug side effects a key factor in reduced quality of life for kidney transplant patients 2Health News:Drug side effects a key factor in reduced quality of life for kidney transplant patients 3Health News:Amid the flu epidemic, don't forget RSV in young children 2Health News:Amid the flu epidemic, don't forget RSV in young children 3Health News:BridgeGate Launches New Healthcare Integration and Interoperability Products 2Health News:BridgeGate Launches New Healthcare Integration and Interoperability Products 3Health News:BridgeGate Launches New Healthcare Integration and Interoperability Products 4
...committee, House Committee on International Relati...ouse to house AIDS testing and counseling as done ... as been found very effective in early diagnosis o...ling and testing helps in maintaining the privacy ...
...University of New South Wales scientists resulted ...eatment can be life threatening and resulted in ea...rough because //they identified that the patients ...tudy had more than 5000 people participating from ...
...ersity of Texas Southwestern Medical Center in Dal... experimental mice resulted in memory loss similar...ere trained to identify food treats buried in the ...le for learning and memory. After deletion the mic...
...in the Indian Sate of Uttar Pradesh have resumed w...t is reported to have declared their strike illega...abad, Kanpur, Meerut, Lucknow, Agra, Jhansi and Go...s Medical University (KGMU) and police recruits. ...
...ng of life support to an 11-year-old girl after do...onths in a coma. The coma was allegedly caused by ...r and adoptive mother. The girl had been on a resp.... Haleigh was comatose with severe brain i...
...n and yummy cereals is facing the wrath of a consu...arketing practices aimed at kids. In fact they ar...runs Nickelodeon channel as well. //According to t... Still, the Center added, if its demands were not ...
Other Medicine News:Health News:Breaks In The HIV Treatment Resulted In Devastating Results. 2Health News:Junior Doctors Put An End To Strike 2
(Date:11/23/2009)...ov.23/PRNewswire-FirstCall/--WoundManagementTechno...providerofspecialtymedicalproducts,announcedthatit...prehensivemanagementbusinessupdatetoillustratethed...9salesincreased33.5%to$102,926vs.Q32008salesof$77,...dto$3,327,892vs.Q32008shareholderequityof$(321,257...
(Date:11/23/2009)...v.23/PRNewswire-FirstCall/--Pharmasset,Inc.(Nasdaq...edbyitspartnerRoche(SWX:ROG.VX;RO.S,OTCQX:RHHBY),w...intheongoingphase2btrialofRG7128,afirst-in-classnu...chronichepatitisCvirus(HCV)infection.Thedecisionwa...nitoringCommittee(DMC)ofallavailablesafetydatafrom...
(Date:11/23/2009)...ZER,Pa.,Nov.23/PRNewswire-FirstCall/--CeptionThera...y,andCephalon,Inc.(Nasdaq: CEPH )todayannouncedres...eslizumab)asatreatmentforpediatriceosinophilicesop...entintheco-primaryendpointsofchangesinesophagealeo...aindicatedthatpatientstreatedwithCINQUILshowedasta...
Breaking Medicine Technology:Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 2Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 3Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 4Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 2Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 3Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 4Shamir Optical Industry Ltd Reports Second Quarter 2009 Results 54429 1Shamir Optical Industry Ltd Reports Second Quarter 2009 Results 54429 2Shamir Optical Industry Ltd Reports Second Quarter 2009 Results 54429 3Shamir Optical Industry Ltd Reports Second Quarter 2009 Results 54429 4Shamir Optical Industry Ltd Reports Second Quarter 2009 Results 54429 5Shamir Optical Industry Ltd Reports Second Quarter 2009 Results 54429 6Shamir Optical Industry Ltd Reports Second Quarter 2009 Results 54429 7Shamir Optical Industry Ltd Reports Second Quarter 2009 Results 54429 8Shamir Optical Industry Ltd Reports Second Quarter 2009 Results 54429 9Shamir Optical Industry Ltd Reports Second Quarter 2009 Results 54429 10Impact of cannabis on bones changes with age study finds 54427 1Interventional radiology treatment for uterine fibroids 3A Safe nonsurgical option 54424 1Interventional radiology treatment for uterine fibroids 3A Safe nonsurgical option 54424 2Interventional radiology treatment for uterine fibroids 3A Safe nonsurgical option 54424 3
...ansdel,Pharmaceuticals, Inc. (OTC Bulletin Board: ...and Drug Administration,s ("FDA") review of its Ph...e 3 clinical program for its,novel topical cream b...),Ketotransdel(TM). Transdel Pharmaceuticals is a ...lopment and commercialization of non-invasive,topi...
...ular Structures Needed for siRNA ...8 Silence Therapeutics plc,(AIM:SLN) Europe,s lea...ments on two recent journal articles: Nature(1) "S...ssion by siRNA via TLR3" Mark E.,Kleinman, et. al....,siRNA/Liposome Complexes in Mice is Sequence-Inde...
Other Medicine Technology:Transdel Pharmaceuticals Advances Lead Topical Pain Drug into Phase 3 Program 2Transdel Pharmaceuticals Advances Lead Topical Pain Drug into Phase 3 Program 3Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach 2Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach 3Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach 4
SMZ-660
SMZ-645
SMZ-1500
Achroplan Wasser objectives
Medicine Products: